Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $79,076 - $90,916
400 New
400 $90,000
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $203,720 - $248,970
1,000 Added 142.86%
1,700 $400,000
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $1.35 Million - $1.73 Million
-6,600 Reduced 90.41%
700 $143,000
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $4.81 Million - $6.25 Million
-22,500 Reduced 75.5%
7,300 $1.71 Million
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $5.53 Million - $6.35 Million
21,300 Added 250.59%
29,800 $7.86 Million
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $244,440 - $282,789
-900 Reduced 9.57%
8,500 $2.67 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $219,856 - $246,671
800 Added 9.3%
9,400 $2.65 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $7.78 Million - $8.59 Million
-30,900 Reduced 78.23%
8,600 $2.37 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $3.46 Million - $4.31 Million
16,900 Added 74.78%
39,500 $10.1 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $3.68 Million - $4.22 Million
19,700 Added 679.31%
22,600 $4.6 Million
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $4.43 Million - $5.33 Million
-26,500 Reduced 90.14%
2,900 $545,000
Q2 2020

Aug 14, 2020

SELL
$113.31 - $182.44 $3.63 Million - $5.84 Million
-32,000 Reduced 52.12%
29,400 $4.88 Million
Q1 2020

May 14, 2020

BUY
$104.32 - $195.28 $4.44 Million - $8.32 Million
42,600 Added 226.6%
61,400 $7.76 Million
Q4 2019

Feb 13, 2020

BUY
$163.48 - $173.61 $2.71 Million - $2.88 Million
16,600 Added 754.55%
18,800 $3.18 Million
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $317,152 - $380,380
2,200 New
2,200 $380,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.